|

CIML-NK Cells Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Children's Hospital Medical Center, Cincinnati2

Indications

  • Cancer2
  • Neuroblastoma1
  • Acute Myeloid Leukemia1

Cincinnati, Ohio2 trials

Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)

Cincinnati Children's Hospital Medical Center

Phase 1/2
Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma

Cincinnati Children's Hospital Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.